10 Feb 2021
Israel’s swift vaccination rollout has made it the largest real-world study of Pfizer’s COVID-19 vaccine. Results are trickling in, and they are promising.
More than half of eligible Israelis - about 3.5 million people - have now been fully or partly vaccinated. Older and at-risk groups, the first to be inoculated, are seeing a dramatic drop in illnesses.
Among the first fully vaccinated group there was a 53% reduction in new cases, a 39% decline in hospitalizations, and a 31% drop in severe illnesses from mid-January until Feb. 6, said Eran Segal, data scientist at the Weizmann Institute of Science in Rehovot, Israel.